Invited critical reviewMalondialdehyde as biomarker of oxidative damage to lipids caused by smoking
Section snippets
Oxidants, oxidation and cellular targets
As originally defined by Sies [1], oxidative stress is an imbalance between oxidants and antioxidants on a cellular or individual level. Oxidative damage is one result of such an imbalance and includes oxidative modification of cellular macromolecules, induction of cell death by apoptosis or necrosis, as well as structural tissue damage. The present review is going to focus on one particular source of oxidative stress (smoking) and one particular biomarker of oxidative damage (malondialdehyde,
Biomarker criteria
Halliwell and Poulsen recently published a set of 8 criteria describing the ideal biomarker of oxidative stress including both an established relationship to disease and various practical considerations on stability and cost of analysis [4].
Although several criteria are without doubt required to adequately describe a biomarker, the entire basis of the biomarker phenomenon is the measurement of a compound that directly reflects certain biological events related to the pathogenesis of a disease
Measurement of malondialdehyde
One highly important criterion to be fulfilled by a potential biomarker is that it should produce identical results when a given sample is analyzed in different laboratories [4]. For MDA, this criterion remains a major challenge due to an almost unlimited number of assay variations in use worldwide the diversity of which by itself prevents a general acceptance of MDA as valid biomarker of oxidative damage to lipids. MDA has been quantified since the sixties and the original principles of
Oxidative stress and smoking
As mentioned earlier, tobacco smoke contains large numbers of gas and tar phase radicals and other oxidants capable of inducing oxidative stress. Measurements of antioxidants as biomarkers of oxidative stress have consistently confirmed that smokers suffer from increased oxidative stress compared with non‐smokers [23], [24], [25], [26], [27]. Although smokers also have a poorer diet than non‐smokers, more detailed studies with matched dietary intakes have shown that at least vitamin C and
Conclusion
The present review focuses on two aspects of MDA as a biomarker of lipid oxidation: the validity of MDA as a biomarker of oxidative stress in general and the specific effect of smoking on MDA/TBARS status. In the evaluation of MDA and TBARS as possible biomarkers of lipid oxidation, the wide ranges of data reported for healthy non‐smoking volunteers are important. Clearly, these ranges demonstrate that MDA so far can only be regarded as a relative rather than an absolute biomarker of lipid
References (90)
- et al.
Formation of malonaldehyde from lipid oxidation products
Biochim Biophys Acta
(1983) - et al.
Chemistry and biochemistry of 4‐hydroxynonenal, malonaldehyde and related aldehydes
Free Radic Biol Med
(1991) - et al.
On the mechanism of prostacyclin and thromboxane A2 biosynthesis
J Biol Chem
(1989) The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress
Life Sci
(1991)Lipid peroxidation‐DNA damage by malondialdehyde
Mutat Res
(1999)- et al.
Malondialdehyde determination as index of lipid peroxidation
Methods Enzymol
(1990) - et al.
Determination of aldehydic lipid peroxidation products: malonaldehyde and 4‐hydroxynonenal
Methods Enzymol
(1990) - et al.
Determination of malondialdehyde by ion‐pairing high‐performance liquid chromatography
Anal Biochem
(1985) - et al.
Detection of malonaldehyde by high‐performance liquid chromatography
Methods Enzymol
(1984) - et al.
Determination of free malondialdehyde in human serum by high‐performance liquid chromatography
Anal Biochem
(2002)